Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

SUMO2 antibody

The Mouse Monoclonal anti-SUMO2 antibody has been validated for WB, IHC, IF, FACS and StM. It is suitable to detect SUMO2 in samples from Human.
Catalog No. ABIN6940601

Quick Overview for SUMO2 antibody (ABIN6940601)

Target

See all SUMO2 Antibodies
SUMO2 (Small Ubiquitin Related Modifier 2 (SUMO2))

Reactivity

  • 104
  • 40
  • 36
  • 3
  • 2
  • 1
  • 1
  • 1
Human

Host

  • 83
  • 25
  • 1
Mouse

Clonality

  • 84
  • 26
Monoclonal

Conjugate

  • 59
  • 10
  • 8
  • 7
  • 5
  • 5
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This SUMO2 antibody is un-conjugated

Application

  • 73
  • 54
  • 39
  • 21
  • 13
  • 11
  • 11
  • 9
  • 7
  • 6
  • 4
  • 1
  • 1
  • 1
Western Blotting (WB), Immunohistochemistry (IHC), Immunofluorescence (IF), Flow Cytometry (FACS), Staining Methods (StM)

Clone

SM23-496
  • Specificity

    This MAb reacts with both SUMO-2 and SUMO-3. The small ubiquitin-related modifier (SUMO) proteins, which include SUMO-1, 2 and 3, belong to the ubiquitin-like protein family. Like ubiquitin, the SUMO proteins are synthesized as precursor proteins that undergo processing before conjugation to target proteins. Also, both utilize the E1, E2 and E3 cascade enzymes for conjugation. However, SUMO and ubiquitin differ with respect to targeting. Ubiquitination predominantly targets proteins for degradation, whereas sumoylation targets proteins to a variety of cellular processing, including nuclear transport, transcriptional regulation, apoptosis and protein stability. The unconjugated SUMO-1, 2 and 3 proteins localize to the nuclear membrane, nuclear bodies and cytoplasm, respectively. SUMO-1 utilizes Ubc9 for conjugation to several target proteins, which include MDM2, p53, PML and RanGap1. SUMO-2 and 3 contribute to a greater percentage of protein modification than does SUMO-1. In addition, SUMO-3 regulates beta-Amyloid generation and may be critical in the onset or progression of Alzheimer's disease.

    Cross-Reactivity (Details)

    Predicted to show a broad species reactivity.

    Purification

    Purified by Protein A/G

    Immunogen

    Recombinant human SUMO2 protein

    Isotype

    IgG1 kappa
  • Application Notes

    Positive Control: MCF-7, HepG2, HeLa cells. Breast carcinoma.

    Known Application: Flow Cytometry (1-2 μg/million cells), Immunofluorescence (1-2 μg/mL), Western Blot (1-2 μg/mL), Immunohistochemistry (Formalin-fixed) (1-2 μg/mL for 30 minutes at RT)(Staining of formalin-fixed tissues requires boiling tissue sections in 10 mM citrate buffer, pH 6.0, for 10-20 min followed by cooling at RT for 20 minutes)Optimal dilution for a specific application should be determined.

    Restrictions

    For Research Use only
  • Concentration

    200 μg/mL

    Buffer

    10 mM PBS with 0.05 % BSA & 0.05 % azide.

    Preservative

    Sodium azide

    Precaution of Use

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Storage

    4 °C,-80 °C

    Storage Comment

    Antibody with azide - store at 2 to 8°C. Antibody without azide - store at -20 to -80°C. Antibody is stable for 24 months. Non-hazardous. No MSDS required.

    Expiry Date

    24 months
  • Target

    SUMO2 (Small Ubiquitin Related Modifier 2 (SUMO2))

    Alternative Name

    SUMO2 & SUMO3

    Molecular Weight

    11-13kDa

    Gene ID

    6613, 6612

    UniProt

    P61956, P55854

    Pathways

    Methionine Biosynthetic Process
You are here:
Chat with us!